reports Brad Spellberg, MD. Vabomere combines two existing products, the antibiotic meropenem and vaborbactam, which inhibits certain mechanisms that bacteria use to resist antibiotics.
The elderly, those who are immunocompromised and patients with cancer or other serious conditions are especially at risk for an antibiotic-resistant urinary track infection (UTI) caused by a strain of bacteria known as carbapenem-resistant enterobacteriaceae (CRE), Vabomere is given intravenously.
Source: Bottom Line Personal November 2017 Brad Spellberg, MD, is professor of clinical medicine at the Keck School of Medicine, University of Southern California, Los Angeles, and author of Rising Plague.
IF YOU LIKE THESE POSTS. PLEASE CONSIDER CLICKING THE DONATION BUTTON ABOVE. THANK YOU!